Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9429145 | Neuroscience Letters | 2005 | 5 Pages |
Abstract
Propentofylline is a phosphodiesterase inhibitor that has been shown to attenuate the onset of morphine tolerance when administered intrathecally to rats. The present studies examined whether systemic administration could be effective in attenuating morphine tolerance in non-injured rodents using a similar dosing paradigm. Propentofylline at 10, 30, or 50Â mg/kg, administered intraperitoneally once daily for 5 days, was unable to attenuate morphine tolerance established by twice daily administration of 10Â mg/kg morphine. These results suggest that direct delivery of propentofylline to the central nervous system (CNS) may be required in order to attenuate morphine tolerance.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Jennifer A. Shumilla, Isa Samuels, Kirk W. Johnson, John R. Forsayeth,